Around 1 in 10 babies are in need of some form of stabilisation at birth. The heart rate of the baby is critical for guiding the stabilisation or resuscitation process; however current monitoring methods do not always provide an early enough or sometimes an accurate enough heart rate. This can lead to uncertainty in the management of the baby’s care.
What we do
Accurate, rapid measurements benefit clinical staff by enabling them to make confident decisions more quickly and to focus on performing procedures in time critical situations.
SurePulse may help reduce the time patients spend in neonatal intensive care and reduce costs for healthcare organisations.
Babies born in Europe every year need some form of resuscitation
Learn moreWhat this means
About one in ten babies need some form of help in the first few minutes after birth to stimulate breathing and to ensure the heart is beating properly. That adds up to a staggering 80,000 babies in the UK, more than 200 each day, and 14 million worldwide each year.
Learn more
#Nottingham venture @SurePulseMed is giving babies the 'best start to life'.
The business is growing: taking their staff to 15 within 3 years.
There are loads of exciting jobs in #science 🔬🚀🧬👉 https://t.co/HV0Z7PclqR
#FutureJobs #MidlandsEngine #BSW19 #INSTILS @MedilinkEM
Just published! The AHSN Network #MedTech review is essential reading for companies wanting to develop and roll out their innovations into the NHS. Great to see @SurePulseMed featured an innovation developed at @UniofNottingham. Read more here: https://t.co/Gv5t01SnVa
Find out more about the #INSTILS project - and see examples of three companies which have benefited from Project Support - https://t.co/n8f83f2PGu @NeaterSolutions @SurePulseMed & Wellness Lab!
